Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-001870
Filing Date
2025-03-10
Accepted
2025-03-10 13:02:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 6617
  Complete submission text file 0001959173-25-001870.txt   8043
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Subject) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-19319 | Film No.: 25722948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
WAGNER CHARLES F JR (Reporting) CIK: 0001223348 (see all company filings)

Type: 144